Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Plymate

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Tissue Engineering. Part C, Methods|February 5, 2013
Capillary force seeding of sphere-templated hydrogels for tissue-engineered prostate cancer xenograftsThomas J Long, Marc Takeno, Cynthia C Sprenger, et al.
Endocrinology|May 8, 2004
Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53Moran Rubinstein, Gila Idelman, Stephen R Plymate, et al.
Journal of Cellular Biochemistry|April 28, 2006
Interaction of IGF signaling and the androgen receptor in prostate cancer progressionJennifer D Wu, Kathy Haugk, Libby Woodke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent mannerHagit Schayek, Kathy Haugk, Shihua Sun, et al.
Cancer|November 13, 2004
Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulinChu Chen, S Kay Lewis, Lynda Voigt, et al.
European Urology|August 29, 2022
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate CancerAdam G Sowalsky, Stephen R Plymate, Michael C Haffner, et al.
Cancer Treatment and Research Communications|January 31, 2021
AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualificationAdam G Sowalsky, Adam Sharp, Shana Y Trostel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptorChu Chen, Robert Freeman, Lynda F Voigt, et al.
The Journal of Clinical Investigation|August 18, 2004
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancerJennifer D Wu, Lily M Higgins, Alexander Steinle, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 26, 2009
Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) geneHagit Schayek, Itay Bentov, Itay Rotem, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Tissue Engineering. Part C, Methods|February 5, 2013
Capillary force seeding of sphere-templated hydrogels for tissue-engineered prostate cancer xenograftsThomas J Long, Marc Takeno, Cynthia C Sprenger, et al.
Endocrinology|May 8, 2004
Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53Moran Rubinstein, Gila Idelman, Stephen R Plymate, et al.
Journal of Cellular Biochemistry|April 28, 2006
Interaction of IGF signaling and the androgen receptor in prostate cancer progressionJennifer D Wu, Kathy Haugk, Libby Woodke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent mannerHagit Schayek, Kathy Haugk, Shihua Sun, et al.
Cancer|November 13, 2004
Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulinChu Chen, S Kay Lewis, Lynda Voigt, et al.
European Urology|August 29, 2022
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate CancerAdam G Sowalsky, Stephen R Plymate, Michael C Haffner, et al.
Cancer Treatment and Research Communications|January 31, 2021
AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualificationAdam G Sowalsky, Adam Sharp, Shana Y Trostel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptorChu Chen, Robert Freeman, Lynda F Voigt, et al.
The Journal of Clinical Investigation|August 18, 2004
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancerJennifer D Wu, Lily M Higgins, Alexander Steinle, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 26, 2009
Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) geneHagit Schayek, Itay Bentov, Itay Rotem, et al.
Pageof 12